Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ia/Ib Multicenter Trial of Mogamulizumab for Advanced or Recurrent Cancer.

NCT01929486 is registered in ClinicalTrials.gov with Aichi Medical University as lead sponsor.

NCT NCT01929486
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01929486 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ia/Ib Multicenter Trial of Mogamulizumab for Advanced or Recurrent Cancer.
Lead sponsor
Aichi Medical University
Phase
Phase 1
Overall status
Unknown status
Start date
February 28, 2013
Completion date
Not reported
Enrollment
58 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor